By Press Association 2021
Nurse Kathe Olmstead, right, gives a volunteer an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna
The head of the Food and Drug Administration (FDA) has said his agency will move to quickly authorise a second Covid-19 vaccine for the US to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.
FDA commissioner Stephen Hahn said in a statement that regulators have communicated their plans to pharmaceutical company Moderna, which co-developed the vaccine with the National Institutes of Health.
The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18-years-old and up.
The FDA has signalled it will approve the Moderna vaccine. By Press Association Friday 18 Dec 2020, 7:26 AM Dec 18th 2020, 7:26 AM 7,384 Views 9 Comments
Image: Shutterstock/89stocker
Image: Shutterstock/89stocker
THE HEAD OF the US Food and Drug Administration (FDA) has said the agency will move to quickly authorise Moderna’s Covid-19 vaccine.
Stephen Hahn’s announcement came just hours after the vaccine won the endorsement of a government advisory panel.
The FDA commissioner said in a statement that regulators have communicated their plans to the pharmaceutical company, which co-developed the vaccine with the National Institutes of Health.
The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18-years-old and up.